| Serial Number | 79102816 |
| Word Mark | LEADING LIGHT FOR LIFE |
| Filing Date | Friday, July 22, 2011 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Thursday, July 22, 2021 |
| Registration Number | 4192508 |
| Registration Date | Tuesday, August 21, 2012 |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, June 5, 2012 |
| Goods and Services | [ Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseases, namely, benign prostatic hyperplasia, over active bladder; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, acne medication; pharmaceutical preparations for the treatment of hematological diseases, namely, anemia; pharmaceutical preparations for the treatment of immunological diseases, namely, rejection in transplantation, autoimmune diseases, immunologic deficiency syndromes, allergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer, namely, tumor suppressing agents; antibiotics, antifungals, anti-viral drugs; vaccines for the treatment of infectious diseases; diagnostic preparations for use in testing urine, fecal occult blood and other blood diseases, namely, anemia, leukemia, hemophilia; pharmaceuticals for human use, namely, anthelmintics; sanitary preparations, namely, germicides ] |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | [ Testing, inspection or research of pharmaceuticals; ] providing medical research information in the field of pharmaceuticals |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | G - NOT AVAILABLE |
| Class Status Date | Thursday, October 5, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | H - NOT AVAILABLE |
| Class Status Date | Thursday, July 22, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Astellas Pharma Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Chuo-ku, Tokyo 103-841 JP |
| Party Name | Astellas Pharma Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Party Name | Astellas Pharma Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Event Date | Event Description |
| Saturday, February 12, 2022 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED |
| Saturday, February 12, 2022 | DEATH OF INTERNATIONAL REGISTRATION |
| Saturday, August 21, 2021 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED |
| Friday, October 23, 2020 | NEW REPRESENTATIVE AT IB RECEIVED |
| Wednesday, January 8, 2020 | REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED |
| Tuesday, December 10, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 6, 2018 | PARTIAL INVALIDATION PROCESSED BY THE IB |
| Thursday, June 7, 2018 | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Thursday, June 7, 2018 | INVALIDATION PROCESSED |
| Tuesday, June 5, 2018 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Thursday, October 5, 2017 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED |
| Thursday, October 5, 2017 | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. |
| Thursday, October 5, 2017 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Tuesday, September 5, 2017 | TEAS SECTION 71 & 15 RECEIVED |
| Monday, August 21, 2017 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Monday, July 15, 2013 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Saturday, July 13, 2013 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Friday, May 31, 2013 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Friday, December 14, 2012 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, December 10, 2012 | NOTIFICATION PROCESSED BY IB |
| Thursday, November 29, 2012 | FINAL DISPOSITION NOTICE SENT TO IB |
| Thursday, November 29, 2012 | FINAL DISPOSITION PROCESSED |
| Wednesday, November 21, 2012 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, August 21, 2012 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 5, 2012 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 5, 2012 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 16, 2012 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, May 16, 2012 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, May 16, 2012 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Saturday, April 28, 2012 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, April 24, 2012 | ASSIGNED TO LIE |
| Thursday, April 5, 2012 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 4, 2012 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, April 3, 2012 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 3, 2012 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, November 20, 2011 | REFUSAL PROCESSED BY IB |
| Friday, October 28, 2011 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, October 28, 2011 | REFUSAL PROCESSED BY MPU |
| Friday, October 28, 2011 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, October 27, 2011 | NON-FINAL ACTION WRITTEN |
| Thursday, October 27, 2011 | ASSIGNED TO EXAMINER |
| Friday, October 14, 2011 | APPLICATION FILING RECEIPT MAILED |
| Monday, October 10, 2011 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, October 7, 2011 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, October 6, 2011 | SN ASSIGNED FOR SECT 66A APPL FROM IB |